Johnson & Johnson Share Holder Equity 1986-2025 | JNJ

Johnson & Johnson share holder equity from 1986 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
  • Johnson & Johnson share holder equity for the quarter ending June 30, 2025 was $78.473B, a 9.69% increase year-over-year.
  • Johnson & Johnson share holder equity for 2024 was $71.49B, a 3.95% increase from 2023.
  • Johnson & Johnson share holder equity for 2023 was $68.774B, a 10.46% decline from 2022.
  • Johnson & Johnson share holder equity for 2022 was $76.804B, a 3.76% increase from 2021.
Johnson & Johnson Annual Share Holder Equity
(Millions of US $)
2024 $71,490
2023 $68,774
2022 $76,804
2021 $74,023
2020 $63,278
2019 $59,471
2018 $59,752
2017 $60,160
2016 $70,418
2015 $71,150
2014 $69,752
2013 $74,053
2012 $64,826
2011 $57,080
2010 $56,579
2009 $50,588
2008 $42,511
2007 $43,319
2006 $39,318
2005 $38,710
2004 $31,813
2003 $26,869
2002 $22,697
2001 $24,233
2000 $20,395
1999 $16,213
1998 $13,590
1997 $12,359
1996 $10,836
1995 $9,045
1994 $7,122
1993 $5,568
1992 $5,171
1991 $5,626
1990 $4,900
1989 $4,148
1988 $3,503
1987 $3,485
1986 $2,824
1985 $3,351
Johnson & Johnson Quarterly Share Holder Equity
(Millions of US $)
2025-06-30 $78,473
2025-03-31 $78,109
2024-12-31 $71,490
2024-09-30 $70,158
2024-06-30 $71,538
2024-03-31 $70,020
2023-12-31 $68,774
2023-09-30 $71,228
2023-06-30 $76,409
2023-03-31 $70,869
2022-12-31 $76,804
2022-09-30 $74,599
2022-06-30 $76,357
2022-03-31 $74,709
2021-12-31 $74,023
2021-09-30 $70,272
2021-06-30 $69,580
2021-03-31 $65,834
2020-12-31 $63,278
2020-09-30 $64,473
2020-06-30 $62,978
2020-03-31 $61,294
2019-12-31 $59,471
2019-09-30 $58,210
2019-06-30 $60,785
2019-03-31 $58,955
2018-12-31 $59,752
2018-09-30 $64,626
2018-06-30 $62,889
2018-03-31 $63,255
2017-12-31 $60,160
2017-09-30 $73,979
2017-06-30 $71,922
2017-03-31 $70,341
2016-12-31 $70,418
2016-09-30 $72,769
2016-06-30 $72,473
2016-03-31 $72,647
2015-12-31 $71,150
2015-09-30 $71,554
2015-06-30 $71,131
2015-03-31 $67,878
2014-12-31 $69,752
2014-09-30 $76,591
2014-06-30 $78,048
2014-03-31 $76,582
2013-12-31 $74,053
2013-09-30 $69,804
2013-06-30 $69,665
2013-03-31 $66,855
2012-12-31 $64,826
2012-09-30 $63,761
2012-06-30 $60,434
2012-03-31 $61,366
2011-12-31 $57,080
2011-09-30 $61,527
2011-06-30 $62,132
2011-03-31 $59,863
2010-12-31 $56,579
2010-09-30 $57,291
2010-06-30 $52,851
2010-03-31 $52,914
2009-12-31 $50,588
2009-09-30 $50,384
2009-06-30 $46,247
2009-03-31 $43,791
2008-12-31 $42,511
2008-09-30 $45,734
2008-06-30 $46,435
2008-03-31 $45,625
2007-12-31 $43,319
2007-09-30 $43,573
2007-06-30 $43,122
2007-03-31 $40,928
2006-12-31 $39,318
2006-09-30 $40,573
2006-06-30 $40,742
2006-03-31 $41,123
2005-12-31 $38,710
2005-09-30 $36,847
2005-06-30 $35,169
2005-03-31 $33,654
2004-12-31 $31,813
2004-09-30 $31,513
2004-06-30 $30,052
2004-03-31 $28,494
2003-12-31 $26,869
2003-09-30 $25,738
2003-06-30 $24,437
2003-03-31 $24,036
2002-12-31 $22,697
2002-09-30 $22,085
2002-06-30 $21,891
2002-03-31 $23,723
2001-12-31 $24,233
2001-09-30 $23,734
2001-06-30 $22,711
2001-03-31 $20,092
2000-12-31 $20,395
2000-09-30 $18,486
2000-06-30 $17,979
2000-03-31 $17,150
1999-12-31 $16,213
1999-09-30 $15,384
1999-06-30 $14,744
1999-03-31 $14,222
1998-12-31 $13,590
1998-09-30 $13,938
1998-06-30 $13,312
1998-03-31 $12,805
1997-12-31 $12,359
1997-09-30 $12,182
1997-06-30 $11,722
1997-03-31 $11,174
1996-12-31 $10,836
1996-09-30 $10,678
1996-06-30 $10,240
1996-03-31 $9,828
1995-12-31 $9,045
1995-09-30 $8,912
1995-06-30 $8,564
1995-03-31 $7,881
1994-12-31 $7,122
1994-09-30 $6,993
1994-06-30 $6,621
1994-03-31 $6,092
1993-12-31 $5,568
1993-09-30 $5,695
1993-06-30 $5,705
1993-03-31 $5,543
1992-12-31 $5,171
1992-09-30 $5,971
1992-06-30 $5,714
1992-03-31 $5,737
1991-12-31 $5,626
1991-09-30 $5,356
1991-06-30 $5,064
1991-03-31 $4,927
1990-12-31 $4,900
1990-09-30 $4,741
1990-06-30 $4,548
1990-03-31 $4,286
1989-12-31 $4,148
1989-09-30 $3,930
1989-06-30 $3,752
1989-03-31 $3,621
1988-12-31 $3,503
1988-09-30 $3,505
1988-06-30 $3,599
1988-03-31 $3,672
1987-12-31 $3,485
1987-09-30 $3,285
1987-06-30 $3,160
1987-03-31 $3,024
1986-12-31 $2,824
1985-12-31 $3,351
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $450.090B $94.943B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $495.141B 66.87
Novo Nordisk (NVO) Denmark $424.453B 49.78
Merck (MRK) United States $270.018B 37.87
AbbVie (ABBV) United States $264.086B 11.85
AstraZeneca (AZN) United Kingdom $218.471B 19.74
Novartis AG (NVS) Switzerland $218.425B 15.54
Pfizer (PFE) United States $201.199B 7.39
Sanofi (SNY) $132.955B 11.89
Innoviva (INVA) United States $0.953B 10.12